Literature DB >> 33261024

Antisense Transcription across Nucleotide Repeat Expansions in Neurodegenerative and Neuromuscular Diseases: Progress and Mysteries.

Ana F Castro1,2,3, Joana R Loureiro1,2, José Bessa2,4, Isabel Silveira1,2.   

Abstract

Unstable repeat expansions and insertions cause more than 30 neurodegenerative and neuromuscular diseases. Remarkably, bidirectional transcription of repeat expansions has been identified in at least 14 of these diseases. More remarkably, a growing number of studies has been showing that both sense and antisense repeat RNAs are able to dysregulate important cellular pathways, contributing together to the observed clinical phenotype. Notably, antisense repeat RNAs from spinocerebellar ataxia type 7, myotonic dystrophy type 1, Huntington's disease and frontotemporal dementia/amyotrophic lateral sclerosis associated genes have been implicated in transcriptional regulation of sense gene expression, acting either at a transcriptional or posttranscriptional level. The recent evidence that antisense repeat RNAs could modulate gene expression broadens our understanding of the pathogenic pathways and adds more complexity to the development of therapeutic strategies for these disorders. In this review, we cover the amazing progress made in the understanding of the pathogenic mechanisms associated with repeat expansion neurodegenerative and neuromuscular diseases with a focus on the impact of antisense repeat transcription in the development of efficient therapies.

Entities:  

Keywords:  RNA foci; nuclear inclusions; splicing misregulation; trinucleotide repeats

Mesh:

Substances:

Year:  2020        PMID: 33261024      PMCID: PMC7760973          DOI: 10.3390/genes11121418

Source DB:  PubMed          Journal:  Genes (Basel)        ISSN: 2073-4425            Impact factor:   4.096


  224 in total

1.  FMR1 RNA within the intranuclear inclusions of fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Flora Tassone; Christine Iwahashi; Paul J Hagerman
Journal:  RNA Biol       Date:  2004-07-17       Impact factor: 4.652

2.  The prevalence and wide clinical spectrum of the spinocerebellar ataxia type 2 trinucleotide repeat in patients with autosomal dominant cerebellar ataxia.

Authors:  D H Geschwind; S Perlman; C P Figueroa; L J Treiman; S M Pulst
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

3.  Molecular and clinical analyses of spinocerebellar ataxia type 8 in Japan.

Authors:  Y Ikeda; M Shizuka; M Watanabe; K Okamoto; M Shoji
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

4.  Nonallele specific silencing of ataxin-7 improves disease phenotypes in a mouse model of SCA7.

Authors:  Pavitra S Ramachandran; Ryan L Boudreau; Kellie A Schaefer; Albert R La Spada; Beverly L Davidson
Journal:  Mol Ther       Date:  2014-06-16       Impact factor: 11.454

Review 5.  Polyglutamine Repeats in Neurodegenerative Diseases.

Authors:  Andrew P Lieberman; Vikram G Shakkottai; Roger L Albin
Journal:  Annu Rev Pathol       Date:  2018-08-08       Impact factor: 23.472

6.  Common origin of pure and interrupted repeat expansions in spinocerebellar ataxia type 2 (SCA2).

Authors:  Eliana Marisa Ramos; Sandra Martins; Isabel Alonso; Vanessa E Emmel; Maria Luiza Saraiva-Pereira; Laura Bannach Jardim; Paula Coutinho; Jorge Sequeiros; Isabel Silveira
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

7.  Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis.

Authors:  Sorana Ciura; Serena Lattante; Isabelle Le Ber; Morwena Latouche; Hervé Tostivint; Alexis Brice; Edor Kabashi
Journal:  Ann Neurol       Date:  2013-08       Impact factor: 10.422

8.  A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD.

Authors:  Alan E Renton; Elisa Majounie; Adrian Waite; Javier Simón-Sánchez; Sara Rollinson; J Raphael Gibbs; Jennifer C Schymick; Hannu Laaksovirta; John C van Swieten; Liisa Myllykangas; Hannu Kalimo; Anders Paetau; Yevgeniya Abramzon; Anne M Remes; Alice Kaganovich; Sonja W Scholz; Jamie Duckworth; Jinhui Ding; Daniel W Harmer; Dena G Hernandez; Janel O Johnson; Kin Mok; Mina Ryten; Danyah Trabzuni; Rita J Guerreiro; Richard W Orrell; James Neal; Alex Murray; Justin Pearson; Iris E Jansen; David Sondervan; Harro Seelaar; Derek Blake; Kate Young; Nicola Halliwell; Janis Bennion Callister; Greg Toulson; Anna Richardson; Alex Gerhard; Julie Snowden; David Mann; David Neary; Michael A Nalls; Terhi Peuralinna; Lilja Jansson; Veli-Matti Isoviita; Anna-Lotta Kaivorinne; Maarit Hölttä-Vuori; Elina Ikonen; Raimo Sulkava; Michael Benatar; Joanne Wuu; Adriano Chiò; Gabriella Restagno; Giuseppe Borghero; Mario Sabatelli; David Heckerman; Ekaterina Rogaeva; Lorne Zinman; Jeffrey D Rothstein; Michael Sendtner; Carsten Drepper; Evan E Eichler; Can Alkan; Ziedulla Abdullaev; Svetlana D Pack; Amalia Dutra; Evgenia Pak; John Hardy; Andrew Singleton; Nigel M Williams; Peter Heutink; Stuart Pickering-Brown; Huw R Morris; Pentti J Tienari; Bryan J Traynor
Journal:  Neuron       Date:  2011-09-21       Impact factor: 17.173

9.  Repeat-induced epigenetic changes in intron 1 of the frataxin gene and its consequences in Friedreich ataxia.

Authors:  Eriko Greene; Lata Mahishi; Ali Entezam; Daman Kumari; Karen Usdin
Journal:  Nucleic Acids Res       Date:  2007-05-03       Impact factor: 16.971

10.  Altered nucleosome positioning at the transcription start site and deficient transcriptional initiation in Friedreich ataxia.

Authors:  Yogesh K Chutake; Whitney N Costello; Christina Lam; Sanjay I Bidichandani
Journal:  J Biol Chem       Date:  2014-04-15       Impact factor: 5.157

View more
  3 in total

Review 1.  Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing.

Authors:  Mariapaola Izzo; Jonathan Battistini; Claudia Provenzano; Fabio Martelli; Beatrice Cardinali; Germana Falcone
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

2.  Special Issue "Genetic Advances in Neuromuscular Disorders: From Gene Identification to Gene Therapy".

Authors:  Virginia Arechavala-Gomeza; Lidia Gonzalez-Quereda
Journal:  Genes (Basel)       Date:  2021-02-08       Impact factor: 4.096

Review 3.  Molecular Mechanisms in Pentanucleotide Repeat Diseases.

Authors:  Joana R Loureiro; Ana F Castro; Ana S Figueiredo; Isabel Silveira
Journal:  Cells       Date:  2022-01-08       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.